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strated a proapoptotic transcriptome. In vitro, ischemic
AKI activated apoptosis (FasL,Dapk1,Bcl10) and TNF
family (TNFR1,TNFR2,TNF) genes, caspase-3 (100 
1.1 vs 106.5  0.8, P  .00325), and PARP (10  3.5 vs
61.8  20.5, P  .047) vs sham. Etanercept inhibited
RLMVEC inflammatory genes (E-Selectin, ICAM-1, IL-6,
RhoB), caspase-3 activity (100  0.9 vs 102  0.5, P 
.096) and PARP activity (10  2.3 vs 10.9  2.2, P 
.783) vs vehicle during ischemic AKI.
Conclusions: Ischemic AKI drives a proinflammatory
and proapoptotic lung EC transcriptome with TNFR1-
dependent apoptosis. Further study of EC-specific mecha-
nisms of kidney-lung crosstalk during AKI may identify
potential therapeutic targets.
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Objectives: Surgical bypass and dialysis access cre-
ation are common procedures performed in diabetic
patients. Only 45% of patients have autologous vascular
tissue available for use as a conduit for these procedures.
We have developed an alternative conduit composed of a
vascular scaffold seeded with autologous adipose-derived
stem cells (ASC) differentiated into endothelial cells
(EC) to create a non-thrombogenic lumen. Herein, we
examine ASC from diabetic (DM) versus non-diabetics
(NDM) patients in terms of isolation efficiency, prolifer-
ation, commitment towards EC lineage, and seeding
onto a vascular scaffold.
Methods: ASC were isolated from peri-umbilical li-
posuction specimens by collagenase dispersion (DM
n53; NDM n145). Isolation efficiency was defined
by number of ASC isolated per gram of adipose tissue.
Proliferation was assessed by constructing growth curves over
14d. ASC were differentiated in endothelial growth medium
for 3wk. Differentiation was determined by measuring EC-
specific gene expression (CD31, vWF) using qPCR. Lastly,
ASC were seeded onto decellularized vein, flow conditioned
from 0-9 dynes over 5d, and examined using confocal
microscopy.
Results: ASC isolation efficiency did not differ be-
tween DM and NDM patients (224,028 cells/gm vs.
259,345 cells/gm, respectively; P  .21). The growth
curves for DM (n6) and NDM (n6) ASC also ap-
peared similar, with no significant differences observed
in cells counts between days 1-14. After 1, 2, and 3wk in
culture, no significant difference in CD31 or vWF ex-
pression between DM (n6) and NDM (n6) cells was
observed. Finally, retention of ASC to vascular scaffolds
under physiological shear stress was similar between the
two groups.
Conclusions: ASC are isolated from diabetics in
quantities similar to non-diabetics. These cells grow at
similar rates, exhibit differentiation into an EC pheno-
type, and line the lumen of a tissue engineered vascular
graft.
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Objectives: Intimal hyperplasia (IH) is the cause of
most failed arterio-venous fistulae (AVF), resulting in
repeat procedures and leading to increased utilization of
scarce health care resources. Our lab has previously demon-
strated the role of supplemental oxygen (O2) in preventing IH
and smooth muscle cell proliferation (SMCp) at an artery to
graft anastomosis and at the deployment site of an intra-
arterial stent. This study is to examine the effect of supplemen-
tal O2 in preventing IH and SMCp at an AVF in a rabbit
model.
Methods: 96 rabbits were randomized into three
groups: Group 1- control; Group 2- AVF without sup-
plemental O2; and Group 3- AVF with supplemental O2.
Rabbits receiving supplemental O2 received 30% oxygen for
Table. Measurement of intimal hyperplasia at fistula sitea
Day 1 Day 21 Day 42 Day 90
GROUP 1 0.02 0.02 0.02 0.02
GROUP 2 0.02 0.103b 0.209b 0.257b
GROUP 3 0.02 0.049 0.033 0.006b
aRatio of area of intima/media
bP.05 when compared to Group 1
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42 days. Specimens were collected at days 1,3,7,21,42,
and 90. IH and SMCp were measured at the fistula site as
well as in the artery and vein proximal and distal to the
fistula.
Results: IH was first noted at day 3 and significantly
increased through day 90 at all locations in the non-
oxygen supplemented groups. There was no significant
IH noted in the O2 supplemented groups at any location
or any time point Table). SMCp was noted at Day 3
through Day 21 in the non-oxygen supplemented group
while almost no SMCp was noted in the O2 supple-
mented groups at any location or timepoint.
Conclusions: Without O2 supplementation SMCp
begins at day 3 and is no longer noted at day 21 after
creation of an AVF while IH begins by day 3 and increases at
least through day 90 after creation of an AVF. 42 days of 30%
supplementalO2 inhibits both IH and SCMp after creation of
an AVF. This data suggests a role for short-term administra-
tion of low-dose O2 to prevent both IH and SMCp after
creation of an AVF prolonging fistula patency and function.
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Objectives: Treatment options for critical limb isch-
emia (CLI) are limited. Recent evidence has suggested
that even with successful revascularisation, patients often
show little functional improvement. This has been attrib-
uted to a musculopathy that occurs in CLI. Myogenic
progenitor satellite cells (SCs) provide skeletal muscle
with an intrinsic ability to regenerate. It has been shown
that there is an increase in SCs in ischemic muscle,
however their function in ischemia is poorly understood
and we hypothesize that ischemia has a detrimental effect
on SC function.
Methods: Gastrocnemius muscle biopsies were taken
from CLI patients and compared with non ischemic
control biopsies. The phenotypical changes and fre-
quency of satellite cells were investigated using PAX 7
immunohistochemistry and western blot. C2C12 myoblasts
were used in vitro, to investigate the effect of ischemia on
muscle progenitor cell function. Myoblasts were exposed to
simulated ischemia for 24, 48 and 72hrs. Proliferation rates
were assessed using an MTT assay. Differentiation and apo-
ptosis were assessed byMYOD and cleaved caspase 3 western
blotting respectively.
Results: There is an increased expression of PAX 7 in
CLI muscle biopsies, shown by both immunostaining and
western blot analysis, suggesting an increased number of
SCs in ischemic human skeletal muscle (P.05).Myoblasts
cultured in ischemic conditions demonstrated decreased
cell proliferation, reduced myogenic differentiation (de-
creased MYOD expression), and increased apoptosis (in-
creased cleaved caspase 3 expression).
Conclusions: Despite an upregulation of SCs in isch-
emic tissue, their function is suppressed in ischemic condi-
tions and this may be contributing to the poor functional
recovery of patients post revascularisation. Enhancement of
muscle regeneration in ischemiamay be a useful therapeutic
adjunct in the treatment of CLI.
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Objectives: MicroRNAs (miRs) are a class of recently
discovered noncoding endogenous, small RNAs that neg-
atively regulate gene expression. miR-221 is associated with
vascular smooth muscle cell proliferation and inhibition of
apoptosis. We aimed to determine whether miR-221 is
decreased in acutely symptomatic as opposed to stable,
asymptomatic carotid plaques.
Methods: Relative changes in gene expression levels
of miR-221 were compared using a commercial real-time
PCR assay and the 

Ct method. All samples were run in
duplicate; mean and standard error were calculated.
One-way ANOVA with Tukey’s test and Pearson’s cor-
relation were used to determine significance between
groups.
Results: Levels of miR-221were quantified from asymp-
tomatic (n16) and symptomatic (n6) carotid
plaques. In order to capture the acute state of plaque
rupture, patients undergoing urgent CEA (n11) for
acute neurologic symptoms were included. The propor-
tion of miR-221 in urgent compared to asymptomatic
carotid plaques was reduced (.30.16 vs. 1.00.44, P
.039) (see figure). Moreover, a decreasing trend in miR-
221 levels was noted in asymptomatic-to-symptomatic-
to-urgent plaques (R.43, P  .013).
Conclusions: Carotid plaque levels of miR-221 are
decreased in patients presenting with acute neurological
symptoms compared to patients with asymptomatic ca-
rotid disease. As miR-221 levels are decreased in rup-
tured (urgent CEA) carotid plaques, we postulate that
loss of miR-221 may be important in the transition of a
stable to an unstable carotid atherosclerotic plaque and
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